Robert Ikenberg is an experienced professional in market access and health economics, currently serving as the Head of Market Access Oncology at AstraZeneca since 2023. Previously, Ikenberg held various roles at AstraZeneca, including Director of Market Access and Director of Market Access for Europe & Canada from 2017 to 2020. Early in their career, Ikenberg gained valuable insights as a consultant and analyst at IQVIA and as a manager and senior manager at Amgen. Ikenberg completed a Master's degree in Volkswirtschaftslehre from Universität Konstanz and studied Economics at Université de Nantes.
This person is not in any teams
This person is not in any offices